These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 26069285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.
    Nobili V, Cutrera R, Liccardo D, Pavone M, Devito R, Giorgio V, Verrillo E, Baviera G, Musso G.
    Am J Respir Crit Care Med; 2014 Jan 01; 189(1):66-76. PubMed ID: 24256086
    [Abstract] [Full Text] [Related]

  • 3. Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease.
    Nobili V, Carpino G, Alisi A, Franchitto A, Alpini G, De Vito R, Onori P, Alvaro D, Gaudio E.
    Hepatology; 2012 Dec 01; 56(6):2142-53. PubMed ID: 22467277
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New insights in the pathophysiology of chronic intermittent hypoxia-induced NASH: the role of gut-liver axis impairment.
    Aron-Wisnewsky J, Pepin JL.
    Thorax; 2015 Aug 01; 70(8):713-5. PubMed ID: 26082141
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Metabolic profile in obese patients with obstructive sleep apnea. A comparison between patients with insulin resistance and with insulin sensitivity].
    Dumitrache-Rujinski S, Dinu I, Călcăianu G, Erhan I, Cocieru A, Zaharia D, Toma CL, Bogdan MA.
    Pneumologia; 2014 Aug 01; 63(2):100-2, 104-6. PubMed ID: 25241557
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease.
    Pulixi EA, Tobaldini E, Battezzati PM, D'Ingianna P, Borroni V, Fracanzani AL, Maggioni M, Pelusi S, Bulgheroni M, Zuin M, Fargion S, Montano N, Valenti L.
    PLoS One; 2014 Aug 01; 9(4):e96349. PubMed ID: 24763757
    [Abstract] [Full Text] [Related]

  • 12. Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD.
    Vespasiani-Gentilucci U, Carotti S, Perrone G, Mazzarelli C, Galati G, Onetti-Muda A, Picardi A, Morini S.
    Liver Int; 2015 Feb 01; 35(2):569-81. PubMed ID: 24649857
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Disorders of glucose metabolism and insulin resistance in patients with obstructive sleep apnoea syndrome.
    Bulcun E, Ekici M, Ekici A.
    Int J Clin Pract; 2012 Jan 01; 66(1):91-7. PubMed ID: 22171909
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of resistin in the liver of patients with non-alcoholic fatty liver disease.
    Gierej P, Gierej B, Kalinowski P, Wróblewski T, Paluszkiewicz R, Kobryń K, Ziarkiewicz-Wróblewska B.
    Pol J Pathol; 2017 Jan 01; 68(3):225-233. PubMed ID: 29363914
    [Abstract] [Full Text] [Related]

  • 18. Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease.
    Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, Ray P, Dhiman RK, Chawla Y.
    J Gastroenterol Hepatol; 2016 Jan 01; 31(1):213-21. PubMed ID: 26212089
    [Abstract] [Full Text] [Related]

  • 19. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis.
    Mishra P, Nugent C, Afendy A, Bai C, Bhatia P, Afendy M, Fang Y, Elariny H, Goodman Z, Younossi ZM.
    Liver Int; 2008 Sep 01; 28(8):1080-6. PubMed ID: 18647236
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Wehr A, Baeck C, Ulmer F, Gassler N, Hittatiya K, Luedde T, Neumann UP, Trautwein C, Tacke F.
    PLoS One; 2014 Sep 01; 9(11):e112327. PubMed ID: 25372401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.